Biogen’s Henshaw Insists Data Is Key In Bolstering Biosimilars

 
• By David Wallace
  
Interface
Biogen’s Ian Henshaw Says Data Can Be As Important As Price In Driving Uptake • Source: Shutterstock

More from Biosimilars

More from Products